These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

770 related articles for article (PubMed ID: 26757148)

  • 1. Dry powder inhaler formulation of high-payload antibiotic nanoparticle complex intended for bronchiectasis therapy: Spray drying versus spray freeze drying preparation.
    Yu H; Teo J; Chew JW; Hadinoto K
    Int J Pharm; 2016 Feb; 499(1-2):38-46. PubMed ID: 26757148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new therapeutic avenue for bronchiectasis: Dry powder inhaler of ciprofloxacin nanoplex exhibits superior ex vivo mucus permeability and antibacterial efficacy to its native ciprofloxacin counterpart.
    Tran TT; Vidaillac C; Yu H; Yong VFL; Roizman D; Chandrasekaran R; Lim AYH; Low TB; Tan GL; Abisheganaden JA; Koh MS; Teo J; Chotirmall SH; Hadinoto K
    Int J Pharm; 2018 Aug; 547(1-2):368-376. PubMed ID: 29886096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants.
    Cheow WS; Ng ML; Kho K; Hadinoto K
    Int J Pharm; 2011 Feb; 404(1-2):289-300. PubMed ID: 21093560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison between spray drying and spray freeze drying for dry powder inhaler formulation of drug-loaded lipid-polymer hybrid nanoparticles.
    Wang Y; Kho K; Cheow WS; Hadinoto K
    Int J Pharm; 2012 Mar; 424(1-2):98-106. PubMed ID: 22226876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of inhaled antibiotic liposome versus antibiotic nanoplex in controlling infection in bronchiectasis.
    Tran TT; Yu H; Vidaillac C; Lim AYH; Abisheganaden JA; Chotirmall SH; Hadinoto K
    Int J Pharm; 2019 Mar; 559():382-392. PubMed ID: 30731256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Inhalable Ciprofloxacin Dry Powders for Bronchiectasis Therapy: Mannitol-Silk Fibroin Binary Microparticles with High-Payload and Improved Aerosolized Properties.
    Liu C; Lin L; Huang Z; Wu Q; Jiang J; Lv L; Yu X; Quan G; Li G; Wu C
    AAPS PharmSciTech; 2019 Jan; 20(2):85. PubMed ID: 30673901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of excipients on physical and aerosolization stability of spray dried high-dose powder formulations for inhalation.
    Shetty N; Park H; Zemlyanov D; Mangal S; Bhujbal S; Zhou QT
    Int J Pharm; 2018 Jun; 544(1):222-234. PubMed ID: 29678544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of a dry powder inhaler of ciprofloxacin-loaded polymeric nanomicelles by spray drying process.
    Farhangi M; Mahboubi A; Kobarfard F; Vatanara A; Mortazavi SA
    Pharm Dev Technol; 2019 Jun; 24(5):584-592. PubMed ID: 30431373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spray freeze drying for dry powder inhalation of nanoparticles.
    Ali ME; Lamprecht A
    Eur J Pharm Biopharm; 2014 Aug; 87(3):510-7. PubMed ID: 24657824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-breath dry powder inhaler for delivery of cohesive powders in the treatment of bronchiectasis.
    Young PM; Salama RO; Zhu B; Phillips G; Crapper J; Chan HK; Traini D
    Drug Dev Ind Pharm; 2015 May; 41(5):859-65. PubMed ID: 24811055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of drug alone and carrier-based GLP-1 dry powder inhaler formulations.
    Babenko M; Alany RG; Calabrese G; Kaialy W; ElShaer A
    Int J Pharm; 2022 Apr; 617():121601. PubMed ID: 35181460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhalable combination powder formulations of phage and ciprofloxacin for P. aeruginosa respiratory infections.
    Lin Y; Chang RYK; Britton WJ; Morales S; Kutter E; Li J; Chan HK
    Eur J Pharm Biopharm; 2019 Sep; 142():543-552. PubMed ID: 31398437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming dose limitations using the orbital(®) multi-breath dry powder inhaler.
    Young PM; Crapper J; Philips G; Sharma K; Chan HK; Traini D
    J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):138-47. PubMed ID: 24004178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.
    Li X; Vogt FG; Hayes D; Mansour HM
    J Pharm Sci; 2014 Sep; 103(9):2937-2949. PubMed ID: 24740732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dry powder inhalation containing muco-inert ciprofloxacin and colistin co-loaded liposomes for pulmonary P. Aeruginosa biofilm eradication.
    Wang J; Guo Y; Lu W; Liu X; Zhang J; Sun J; Chai G
    Int J Pharm; 2024 Jun; 658():124208. PubMed ID: 38723731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of Inhalation Phage Powders Using Spray Freeze Drying and Spray Drying Techniques for Treatment of Respiratory Infections.
    Leung SS; Parumasivam T; Gao FG; Carrigy NB; Vehring R; Finlay WH; Morales S; Britton WJ; Kutter E; Chan HK
    Pharm Res; 2016 Jun; 33(6):1486-96. PubMed ID: 26928668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers.
    Li X; Vogt FG; Hayes D; Mansour HM
    J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):81-93. PubMed ID: 24502451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
    Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
    Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical stability and aerosolization performance of dry powder inhalation system containing ciprofloxacin hydrochloride.
    Karimi K; Katona G; Csóka I; Ambrus R
    J Pharm Biomed Anal; 2018 Jan; 148():73-79. PubMed ID: 28965047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a New High-Dose Dry Powder Inhaler (DPI) Based on a Fluidized Bed Design.
    Farkas DR; Hindle M; Longest PW
    Ann Biomed Eng; 2015 Nov; 43(11):2804-15. PubMed ID: 25986955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.